Page 39 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moore Capital Management LP bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,000 shares of the biopharmaceutical company’s stock, valued at approximately $8,217,000. Several other […]

Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., join Regeneron’s Board of Directors...

Rational Advisors LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,060 shares of the biopharmaceutical company’s stock, valued at approximately $1,693,000. Several other institutional investors and […]

MYDA Advisors LLC grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 66.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,000 shares of the biopharmaceutical company’s stock after buying an additional 800 shares during the quarter. […]

Gitterman Wealth Management LLC raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 355 shares of the biopharmaceutical company’s stock after acquiring an additional 42 shares during the quarter. Gitterman […]